Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 15.41 Million | 28.49 Million | 32.92 Million | 39.28 Million | 23.6 Million |
| Net Income | 27.29 Million | 30.41 Million | 28.05 Million | 29.82 Million | 17.35 Million |
| Depreciation & Amortization | 7.21 Million | 6.31 Million | 8.8 Million | 9.89 Million | 7.71 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -13.85 Million | -2.84 Million | 1.8 Million | 4.07 Million | 10.95 Million |
| Other non-cash items | -2.76 Million | -1.8 Million | -1.27 Million | -1.67 Million | -12.41 Million |
| Investing Cash Flow | -27.34 Million | 10.61 Million | -10.97 Million | -15.74 Million | -86.25 Million |
| Investments in PPE | -1.39 Million | -260 Thousand | -1.09 Million | -3.06 Million | -4.42 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -92.52 Million | -19.64 Million | -41.06 Million | -12.51 Million | - |
| Sales/Maturities of investments | 65 Million | 32.11 Million | 31.57 Million | - | - |
| Other Investing Activities | 1.57 Million | -1.58 Million | -587 Thousand | -164 Thousand | -81.83 Million |
| Financing Cash Flow | -23.36 Million | -22.01 Million | -20.42 Million | -16.5 Million | 18.86 Million |
| Debt repayment | -2.57 Million | -2.76 Million | -2.71 Million | -2.64 Million | -217 Thousand |
| Dividends payments | -20.79 Million | -19.25 Million | -17.71 Million | -13.86 Million | -13.22 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 32.3 Million |
| Other Financing Activities | -2.57 Million | - | - | - | 32.3 Million |
| Accounts receivables | -3.85 Million | 342 Thousand | 727 Thousand | 1.31 Million | 4.16 Million |
| Accounts payables | -5.73 Million | - | - | - | - |
| Inventory | -1.53 Million | -8.59 Million | 1.43 Million | -6.04 Million | 8.38 Million |
| Other working capital | -1.66 Million | 355 Thousand | -247 Thousand | 2.81 Million | -1.59 Million |
| Cash at beginning of period | 65.9 Million | 48.8 Million | 47.27 Million | 40.23 Million | 84.02 Million |
| Cash at end of period | 30.61 Million | 65.9 Million | 48.8 Million | 47.27 Million | 40.23 Million |
| Capital Expenditure | -1.39 Million | -260 Thousand | -1.09 Million | -3.06 Million | -4.42 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -35.29 Million | 17.09 Million | 1.53 Million | 7.03 Million | -43.78 Million |
| Free Cash Flow | 14.02 Million | 28.23 Million | 31.83 Million | 36.21 Million | 19.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.89 Million | 4.89 Million | 4.74 Million | 27.29 Million | 4.74 Million | 6.65 Million |
| Depreciation & Amortization | 2.1 Million | 2.1 Million | 1.94 Million | 7.21 Million | 1.94 Million | 1.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -520 Thousand | -520 Thousand | -392.5 Thousand | -13.85 Million | -392.5 Thousand | -3.13 Million |
| Other non-cash items | -3.34 Million | -3.34 Million | -152.5 Thousand | -2.76 Million | -152.5 Thousand | -3.61 Million |
| Investing Cash Flow | 1.37 Million | 1.37 Million | -8.94 Million | -27.34 Million | -8.94 Million | -4.72 Million |
| Investments in PPE | -1.32 Million | -1.32 Million | -391.5 Thousand | -1.39 Million | -391.5 Thousand | -306 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.17 Million | - | - | -92.52 Million | - | - |
| Sales/Maturities of investments | 12.6 Million | - | - | 65 Million | - | - |
| Other Investing Activities | 2.7 Million | 2.7 Million | -8.55 Million | 1.57 Million | -8.55 Million | -4.41 Million |
| Financing Cash Flow | -657.5 Thousand | -657.5 Thousand | -11.04 Million | -23.36 Million | -11.04 Million | -640.5 Thousand |
| Debt repayment | - | - | - | -2.57 Million | - | - |
| Dividends payments | - | - | -10.39 Million | -20.79 Million | -10.39 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -657.5 Thousand | -657.5 Thousand | -648.5 Thousand | - | -648.5 Thousand | -640.5 Thousand |
| Accounts receivables | -674 Thousand | -674 Thousand | 1.76 Million | -3.85 Million | 1.76 Million | -3.69 Million |
| Accounts payables | -1.58 Million | - | - | - | - | - |
| Inventory | -316.5 Thousand | -316.5 Thousand | -2.1 Million | -1.53 Million | -2.1 Million | 1.33 Million |
| Other working capital | 470.5 Thousand | 470.5 Thousand | -55.5 Thousand | -1.66 Million | -55.5 Thousand | -776.5 Thousand |
| Cash at beginning of period | 30.61 Million | - | - | 65.9 Million | - | - |
| Cash at end of period | 3.86 Million | 3.86 Million | -13.84 Million | 30.61 Million | -13.84 Million | -3.8 Million |
| Capital Expenditure | -1.32 Million | -1.32 Million | -391.5 Thousand | -1.39 Million | -391.5 Thousand | -306 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -26.74 Million | 3.86 Million | -13.84 Million | -35.29 Million | -13.84 Million | -3.8 Million |
| Free Cash Flow | 1.82 Million | 1.82 Million | 5.75 Million | 14.02 Million | 5.75 Million | 1.25 Million |
GRT
VOBIF
7747
NTDTY
LIOPY
181710